We are working to sustain our cycle of success into the next decade and beyond by leveraging the scientific expertise we've built in our core disease areas to identify the best science and deliver innovative solutions for patients. said William Hait, M.D., Ph.D., Global Head, Janssen Research & Development, LLC.
and...
With a focus on precision medicine, the company has also invested best-in-class research capabilities in genomics, biotechnology, biomarkers, companion diagnostics, and vaccine platforms, and in accessing early stage breakthrough innovation from the leading innovation hotspots around the world.
http://www.fiercebiotech.com/press-releases/johnson-johnson-pharmaceuticals-segment-poised-continue-driving-growth-more#ixzz2UAdHd1K0
- Forums
- ASX - By Stock
- j&j poised to continue driving growth
PYC
pyc therapeutics limited
Add to My Watchlist
13.3%
!
$1.45

We are working to sustain our cycle of success into the next...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.45 |
Change
0.170(13.3%) |
Mkt cap ! $845.7M |
Open | High | Low | Value | Volume |
$1.30 | $1.45 | $1.30 | $745.4K | 542.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $1.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 22558 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3333 | 1.500 |
1 | 3000 | 1.460 |
1 | 760 | 1.450 |
1 | 355 | 1.420 |
1 | 3558 | 1.405 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 24558 | 2 |
1.460 | 20000 | 1 |
1.470 | 25000 | 1 |
1.475 | 20000 | 1 |
1.490 | 38301 | 2 |
Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online